Related Experiment Video
Updated: Apr 29, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Extended-Spectrum Beta-Lactamase Positivity in Infants with Febrile Urinary Tract Infection: Risk Factors, Pathogen
1Department of Pediatrics, Ümraniye Training and Research Hospital, University of Health Sciences, İstanbul, Türkiye.
Insights
Urinary tract anomalies and prior antibiotic exposure increase the risk of extended-spectrum beta-lactamase (ESBL) producing bacteria in infants with febrile urinary tract infections (UTIs). Klebsiella pneumoniae is increasingly prevalent, necessitating a review of empirical antibiotic strategies.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Resistance
- Clinical Microbiology
Background:
- Febrile urinary tract infections (UTIs) in infants are a common concern.
- Extended-spectrum beta-lactamase (ESBL) producing organisms pose a significant treatment challenge.
- Understanding risk factors and trends is crucial for effective management.
Purpose of the Study:
- Identify risk factors for ESBL positivity in infants with febrile UTI.
- Compare pathogen distribution and antibiotic resistance based on ESBL status.
- Analyze temporal trends in ESBL positivity and associated pathogens.
Main Methods:
- Retrospective, single-center study of 321 infants (1-12 months) with first febrile UTI.
- Comparison of ESBL-positive and ESBL-negative bacterial isolates.
- Analysis of temporal trends in ESBL positivity, pathogens, and empirical antibiotic use.
Main Results:
- Overall ESBL positivity rate was 57.3%.
- Risk factors included urinary tract anomalies, recent antibiotic exposure, and prophylactic antibiotic use.
- Klebsiella pneumoniae and Enterobacter cloacae were more frequent in ESBL-positive isolates, while Escherichia coli was less frequent.
- Higher resistance rates to common antibiotics were observed in ESBL-positive isolates.
- ESBL positivity peaked in 2023, with decreasing E. coli and increasing K. pneumoniae frequencies over time.
Conclusions:
- Urinary tract anomalies and prior antibiotic exposure are key risk factors for ESBL-positive febrile UTI in infants.
- The rising prevalence of K. pneumoniae and high resistance rates necessitate reassessment of empirical antibiotic strategies.
- This highlights the need for vigilant monitoring and adaptive treatment approaches in pediatric populations.
Objective:
To identify the risk factors for extended-spectrum beta-lactamase (ESBL) positivity in infants aged 1-12 months with febrile urinary tract infection (UTI), compare pathogen distribution and antibiotic resistance by ESBL status, and assess year-based changes in ESBL positivity from January 2018 and January 2025.
Materials And Methods:
This retrospective, single-center study evaluated 321 infants (1-12 months) with first febrile UTI, comparing ESBL-positive and ESBL-negative isolates and analyzing temporal trends in ESBL positivity, pathogens, and empirical antibiotic use.
Results:
The overall ESBL positivity rate was 57.3%. The ESBL positivity was significantly associated with urinary tract anomalies (P < .001), antibiotic exposure within the preceding 3 months (P = .003), and prophylactic antibiotic use (P = .013) on urine dipstick testing (P = .001). Pathogen distribution differed significantly between ESBL-positive and ESBL-negative groups (P < .001). Although Escherichia coli was the most common pathogen in both groups, its frequency was lower in the ESBL-positive group compared with the ESBL-negative group (57.07% vs. 79.56%), whereas Klebsiella pneumoniae and Enterobacter cloacae were significantly more frequent among ESBL-positive isolates. The ESBL-positive isolates demonstrated significantly higher resistance rates to beta-lactams, fluoroquinolones, and trimethoprim-sulfamethoxazole (all P < .001). Temporal analyses revealed significant year-to-year variation in ESBL positivity (P < .001), peaking in 2023 (90.48%). Over time, the frequency of E. coli decreased, while K. pneumoniae increased.
Conclusion:
Urinary tract anomalies and prior antibiotic exposure are major risk factors for ESBL-positive febrile UTI in infants. The increasing contribution of K. pneumoniae and high resistance to commonly used empirical antibiotics underscore the need to reassess empirical treatment strategies in this vulnerable population.
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection II: Pathophysiology
Microbiota of the Urogenital Tract
Urinary Tract Infection I: Introduction

